(IBTI) iBonds Dec 2028 Term - Overview
ETF Category: Target Maturity | Exchange: NASDAQ (USA) | Market Cap: 1.711m USD | Total Return: 3.6% in 12m
Avg Turnover: 7.14M
Warnings
No concerns identified
Tailwinds
No distinct edge detected
The iShares iBonds Dec 2028 Term Treasury ETF (IBTI) is a target-maturity exchange-traded fund designed to track an index of U.S. Treasury securities maturing between January 1, 2028, and December 15, 2028. The fund allocates at least 90% of its assets to U.S. Treasury bonds to ensure alignment with the indexs performance and maturity schedule.
Target-maturity ETFs function differently than traditional bond funds by liquidating and returning capital to shareholders once the underlying securities reach maturity. This structure mitigates interest rate risk for investors holding the fund until its 2028 termination date, as the portfolio’s duration naturally shortens over time. U.S. Treasury securities are backed by the full faith and credit of the federal government, typically serving as a benchmark for risk-free rates in fixed-income markets.
Investors can further evaluate the risk-return profile of this specific maturity window by reviewing the detailed analytics available on ValueRay. This fund provides a predictable liquidity event, making it a tool for matching specific future liabilities or managing laddered bond strategies.
- Federal Reserve interest rate pivots shift the net asset value of the fund
- U.S. Treasury yield curve fluctuations impact the bond portfolio market pricing
- Approaching 2028 maturity date reduces duration risk and price volatility for investors
- Fiscal policy and national debt levels influence sovereign credit risk and pricing
- Secondary market liquidity for 2028 Treasuries determines fund tracking error and spreads
As of June 04, 2026, the stock is trading at USD 22.10 with a total of 565,518 shares traded.
Over the past week, the price has changed by +0.00%,
over one month by +0.05%,
over three months by -0.30% and
over the past year by +3.59%.
iBonds Dec 2028 Term has no consensus analysts rating.